The presence of false lumen thrombus is associated with an increase in long-term aorta related morbidity and mortality. These findings may have implications on risk stratification, frequency of surveillance imaging, and future treatments.
TCT-544
The Potential Role of Statin in Patients with Critical Limb Ischemia.
Atsushi Tosaka 1 , Yoshimitsu Soga 2 , Osamu Iida 3 , Masato Nakamura 4 1 Kawakita General Hospital, Tokyo, Tokyo, 2 Kokura Memorial Hospital, Kitakyushu, Japan, 3 Kansai Rosai Hospital, Amagasaki, Hyogo, 4 Toho University Ohashi Medical Center, Tokyo, Japan Background: Revascularization is the optimal treatment to avoid major amputation for critical limb ischemia (CLI) patients. Although previous studies report that statin administration is associated with a reduced risk for cardiovascular events, the efficacy for CLI patients is unclear. In this study, we aimed to compare the outcomes in CLI patients with statin administration and without statin administration after endovascular therapy (EVT). Methods: This study is a subanalysis from Endovascular Treatment for Infra-inguinal Vessel, in patients with critical limb ischemia, -A Prospective, Multi-center, 12 month follow-up Registry in Japan: Olive Registry. From November 2009 to December 2011, a total of 310 patients with CLI who underwent EVT for infrainguinal artery disease were enrolled. The outcome measures were limb salvage and major adverse limb event (MALE). MALE was defined as major amputation or major reintervention including surgical procedure. Results: The mean follow-up period was 294 AE 138 days. Sixty-five percent were male, 26% had statin administration. Rutherford class IV was found in 38 patients, V in 217 patients and VI in 55 patients. Kaplan-Meier survival curve showed that the limb salvage rate at one year was 97.3% in the statin group, 89.7% in the without statin group (P¼0.03). In adjusted model, limb salvage rate and freedom from MALE were statistically higher in the statin group (P<0.01). Conclusions: Statin administration after infrainguinal angioplasty for CLI patients improved limb salvage rate and freedom from MALE.
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The AURORAA registry : 1 year reults using interwoven nitinol stents for extensive distal femoropopliteal occlusive disease.
Peter Goverde 1 , Katrien Lauwers 2 , Sven Vercauteren 2 1 ZNA Stuivenberg Hospital, Antwerp, Belgium, 2 Vascular Clinic ZNA, Antwerp, Belgium
Background: In the endovascular treatment of extensive disease in the distal superficial femoral and popliteal level, you can encounter flow limiting problems, where stent placement is needed after balloon angioplasty. At the moment most of the standard bare nitinol stents will have difficulties in these areas. With the introduction of the Supera stent (IDEV Technologies, Inc., Texas, US) we may have an answer in treating those problematic lesions Methods: Because of the Superas new design; with 6 interwoven nitinol wires, it has extraordinary characteristics : very flexible, kink, fracture and crush resistant together with great radial force. We have treated more than 100 patients with extensive distal femoropopliteal disease (TASC II C & D) with heavy calcifications, occlusions, recurrent disease, stent fractures etc. These lesions, that not responded to balloon angioplasty and that needed stent placement, were al treated with placement of Supera stents. Results: Results of the single centre prospective AURORAA registry : Follow up done by ultrasound. Five patients died of non-interventional causes.. Six months primary patency was more then 90%. Twelve months primary patency was around 81%. We observed further more no stent fractures or flow limiting kinking in this very difficult "to stent" area (distal superficial femoral artery & popliteal artery). Average lesion length: 14 cm; average stent length : 18 cm. Technical success rate :96 % Conclusions: The Supera stent can be a solution when the use of a "classic" nitinol stent is not indicated or favourable , especially in the femoropoliteal area. It has very good patency rates, despite the very difficult region to treat This self expandable stent system can be a necessary complement in your tool box due to its special characteristics
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Safety and feasibility of one day discharge after endovascular revascularization of lower extremities in elderly. Background: The elderly have a high prevalence of peripheral arterial disease (PAD) and it seems that they may be less suitable for a one day discharge after endovascular revascularization (ER) mainly due to a higher ratio in hemorrhage complications. Therefore we sought to evaluate whether the advantages of one day discharge after ER on lower extremities can be safely extended for the elderly. Methods: Between January 2008 and June 2012, 455 ER were performed on lower extremities with Bivalirudin as an anticoagulant. The decision of deployment the vascular closure device (VCD) was left to the operator discretion. Patients 70 years old and older were included to the study group (n¼235). The rest of the patients created the control group (n¼220). The follow up was done at 24 hours and 30 days after TUESDAY, OCTOBER 29, 2013, 3:30 PM-5:30 PM 
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